- Bristol Myers Squibb signs $ 11 billion in cancer drugs with biontech Financial time
- Bristol to pay biontech up to $ 11.1 billion in cancer Bloomberg.com
- Treatment of $ 11 billion: Biontech and Bristol Myers unite their strengths on revolutionary cancer BNT327 Original titan
- Bristol Myers bets $ 1.5 billion on the PD-L1xvegf of Biontech de Biotheus NEW termination points
- Bristol Myers Allied with Biontech on a drug against bispecific cancer Yahoo Finance
Bristol Myers Squibb signs $ 11 billion in cancer drugs with Biontech – Financial Times
